Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Si-Bone (SIBN) EBITDA (2017 - 2025)

Si-Bone has reported EBITDA over the past 9 years, most recently at -$1.6 million for Q4 2025.

  • Quarterly results put EBITDA at -$1.6 million for Q4 2025, up 66.89% from a year ago — trailing twelve months through Dec 2025 was -$18.3 million (up 40.87% YoY), and the annual figure for FY2025 was -$18.3 million, up 40.87%.
  • EBITDA for Q4 2025 was -$1.6 million at Si-Bone, up from -$4.5 million in the prior quarter.
  • Over the last five years, EBITDA for SIBN hit a ceiling of -$1.6 million in Q4 2025 and a floor of -$18.6 million in Q2 2022.
  • Median EBITDA over the past 5 years was -$11.0 million (2023), compared with a mean of -$10.5 million.
  • Biggest five-year swings in EBITDA: tumbled 64.76% in 2021 and later surged 66.89% in 2025.
  • Si-Bone's EBITDA stood at -$14.6 million in 2021, then grew by 23.72% to -$11.1 million in 2022, then increased by 0.86% to -$11.0 million in 2023, then soared by 56.08% to -$4.8 million in 2024, then surged by 66.89% to -$1.6 million in 2025.
  • The last three reported values for EBITDA were -$1.6 million (Q4 2025), -$4.5 million (Q3 2025), and -$5.8 million (Q2 2025) per Business Quant data.